BioQuest serves clients in the healthcare/life sciences industries. From Board of Directors to CEOs and VPs in all types of senior management functions, below is a representation of clients with whom we have worked for.
AltheaDx
San Diego, CA
AltheaDx is a leading provider of manufacturing and development services, supporting researchers worldwide in their advancement of novel therapies.
Althea Technologies
San Diego, CA
Althea Technologies is a leading provider of contract services to the pharmaceutical and biotechnology industry. Althea’s services include cGMP contract manufacturing and biologics production for projects from pre-clinical through commercial production.
ARMGO Pharma Inc. New York, NY
ARMGO Pharma, Inc. is a privately held biopharmaceutical company dedicated to applying original, targeted science to the discovery and development of novel small molecule therapeutics to treat debilitating cardiac, muscular, and neurological disorders. ARMGO has been awarded an exclusive, worldwide license from Columbia University for its ryanodine receptor technology.
BioFocus DPI (A Galapagos Company) South San Francisco, CA
BioFocus offers a full suite of target-to-drug discovery products and services to pharmaceutical and biotech companies, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates. BioFocus also provides adenoviral reagents for rapid identification and validation of novel drug targets, compound libraries as well as ADMET products to select compounds.
Genomic Health Redwood City, CA
Genomic Health, Inc. (Nasdaq: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and the likelihood of chemotherapy benefit in a large portion of early-stage breast cancer patients.
GlobeImmune Inc. Louisville, CO
GlobeImmune is a biopharmaceutical company pioneering the discovery, development and manufacturing of potent, targeted molecular immunotherapies called Tarmogens for the treatment of infectious diseases and cancer.
MDRNA
Bothell, WA
Bothell, WA
MDRNA is focused on realizing the potential of RNAi-based therapeutics through the development of a broad-based, state-of-the-art drug discovery platform built upon industry leading expertise in RNA chemistry and oligonucleotide delivery.
Neurotech Pharmaceuticals, Inc. Lincoln, RI
Neurotech is developing recombinant cell technology for the treatment of chronic retinal diseases. The company’s Encapsulated Cell Technology (ECT) platform enables long-term, sustained delivery of therapeutic factors to the back of the eye.
Presidio Pharmaceuticals
San Francisco, CA
San Francisco, CA
A specialty pharmaceutical company dedicated to development and commercialization of novel and validated small-molecule antiviral therapeutics.
PrimeraDx
Mansfield, MA
Mansfield, MA
Multiplexed quantitative and qualitative assays addressing unmet needs currently impacting infectious disease and cancer diagnostics.
Quidel Corporation
San Diego, CA
San Diego, CA
Quidel Corporation serves to enhance the health and well being of people around the globe through the discovery, development, manufacturing and marketing of rapid diagnostic solutions at the point of care (POC) in infectious diseases and reproductive health. Quidel’s Specialty Products Group (SPG) develops research products in the fields of oncology and bone health with future point-of-care applications.
Revance Therapeutics, Inc
Mountain View, CA
Mountain View, CA
Revance Therapeutics is a clinical-stage specialty biopharmaceutical company devoted to creating the next generation of therapeutic and aesthetic dermatology. The company’s current product pipeline consists of development programs in hyperhidrosis, regeneration of elastin, and regression of fat and cellulite.
Singulex, Inc.
St. Louis, MO
St. Louis, MO
Singulex, Inc. is a bioanalytical company that develops state-of-the-art integrated systems for detecting and counting individual molecules. Singulex is applying its technology and products to low abundance proteomics monitoring, which includes biomarker validation, implementation, and clinical diagnostics.
Takeda Research Investment, Inc. (TRI)
Palo Alto, CA
Palo Alto, CA
TRI is the corporate venture arm of Takeda Pharmaceutical Company Limited
Ventana Medical is the world’s leading supplier of automated diagnostic systems to the anatomical pathology market.
XDx, Inc.
Brisbane, CA
Brisbane, CA
XDx is a molecular diagnostics company focused on the discovery, development and commer-cialization of noninvasive gene expression-based tests for the monitoring of transplant rejection and autoimmune diseases. Their first test, AlloMap® molecular expression testing, was launched in 2005 and when used in conjunction with clinical judgment and assessment of heart graft function, it can help identify heart transplant patients who are at a very low risk of acute cellular rejection.